| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Expenses | ||||||||
| Salaries, benefits and directors' fees | ||||||||
| Office, administrative, and travel | ||||||||
| Professional fees and insurance | ||||||||
| Depreciation | ||||||||
| Share-based payments | ||||||||
| Total value | ||||||||
| Finance income | ||||||||
| Mark-to-market gain (loss) on convertible debentures | ||||||||
| Interest expense on convertible debentures | ||||||||
| Interest on lease liabilities and accretion expense | ||||||||
| Share of net loss from associate | ||||||||
| Loss before taxes | ||||||||
| Net loss | ||||||||
| Change in fair value of convertible debenture attributable to the change in credit risk |